As of the close on Friday, $S&P/ASX 200(XJO.AU)$ closed at 7968.20 on Friday, up 2.66% in the past 5 days.1. $Resmed DRC(RMD.AU)$ +7.35%Tariff Exemption: ResMed’s exports from Australia and Singapore are exempt from U.S. trade tariffs, protecting margins and ensuring global competitiveness.Solid Revenue Growth: Q3 sales rose 8% to $1.3B, meeting expectations and showing consistent performance.Massive Market Opportunity: With new insomnia treatments launching, ResMed targets a 2 billion-person addressable market, supporting long-term growth.2. $Macquarie(MQG.AU)$ +7.17%The $1B from divesting its public asset management unit boosts financial flexibility f